GLP-1 Capsule

GLP-1 capsule provides an oral formulation of a GLP-1 receptor agonist, enabling research into oral peptide delivery and metabolic effects. This formulation addresses one of the key challenges in peptide therapeutics, achieving reliable oral bioavailability for molecules that are typically administered by injection. It is classified under the Capsules & Sprays research category and is studied in the following areas: Oral Peptide Delivery, Metabolic Health, GLP-1 Pathway, Weight Management.

Our GLP-1 Capsule is tested at 99%+ purity via third-party HPLC analysis. Every order ships with a Certificate of Analysis (COA) documenting purity, identity, and endotoxin levels.

GLP-1 Capsule should be stored at Room Temperature. It is supplied as a capsules and is oral administration.

GLP-1 receptor agonist; enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety via hypothalamic signaling (oral delivery form with absorption enhancer)

GLP-1 Capsule has a molecular weight of 4113.58 g/mol. Its amino acid sequence is: GLP-1 receptor agonist (oral formulation).

Yes. Every batch of GLP-1 Capsule is third-party tested and ships with a full Certificate of Analysis (COA) documenting HPLC purity, mass spectrometry identity confirmation, and endotoxin testing results.

~7 days (due to albumin binding and DPP-4 resistance)

In published research, GLP-1 Capsule has been administered via oral administration. All use is for laboratory research purposes only.